iZafe Group AB
STO:IZAFE B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
iZafe Group AB
STO:IZAFE B
|
SE |
|
Navidea Biopharmaceuticals Inc
OTC:NAVB
|
US |
|
American Bank Inc
OTC:AMBK
|
US |
|
Top Shelf International Holdings Ltd
ASX:TSI
|
AU |
|
Danto Holdings Corp
TSE:5337
|
JP |
|
Gemilang International Ltd
HKEX:6163
|
MY |
|
S
|
Shanghai New Vision Microelectronics Co Ltd
SSE:688593
|
CN |
|
C
|
Circa Group AS
OSE:CIRCA
|
NO |
|
AP Moeller - Maersk A/S
CSE:MAERSK B
|
DK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IZAFE B's stock price target?
Not Available
IZAFE B doesn't have any price targets made by Wall Street professionals.
What is iZafe Group AB's Revenue forecast?
Projected CAGR
530%
For the last 14 years the compound annual growth rate for iZafe Group AB's revenue is 46%. The projected CAGR for the next 1 year is 530%.